Drug · DIN 02566605
PMS-DEXTROAMPHETAMINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 24, 2026; first marketed September 24, 2026.
- Drug Identification Number (DIN)
- 02566605
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Controlled drugs (cdsa i)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Dexamfetamine N06BA02
- Class
- Human
- Record last updated
- September 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXTROAMPHETAMINE SULFATE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 10, 2026: NOC 37075Abbreviated New Drug Submission (ANDS)
Other DINs named PMS-DEXTROAMPHETAMINE
- DIN 02447673 · Cancelled Pre Market